Clinical and molecular hepatology

Keyphrases

Publications

2023

Shang-Chin Huang, Chun-Jen Liu
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives. Clinical and molecular hepatology (2023)
Landon L Chan, Stephen L Chan
The prime time for management of hepatocellular carcinoma in Hong Kong. Clinical and molecular hepatology (2023)
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J Tuñón, Javier González-Gallego, José L Mauriz
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications. Clinical and molecular hepatology (2023)
Heejoon Jang, Won Kim
Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors? Clinical and molecular hepatology (2023)
Joo Hyun Oh, Dae Won Jun
The latest global burden of liver cancer: A past and present threat. Clinical and molecular hepatology (2023)
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison. Clinical and molecular hepatology (2023)
Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E Rich, Mazen Noureddin, Amit G Singal, Ju Dong Yang
Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma. Clinical and molecular hepatology (2023)
Sherlot Juan Song, Vincent Wai-Sun Wong
Implications of comorbidities in nonalcoholic fatty liver disease. Clinical and molecular hepatology (2023)
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy. Clinical and molecular hepatology (2023)
Moon Haeng Hur, Jeong-Hoon Lee
The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise. Clinical and molecular hepatology (2023)
Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
A decade of liver organoids: Advancements in disease modeling. Clinical and molecular hepatology (2023)
Margaret Lp Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q Huang
Editorial: HCC surveillance in non-alcoholic fatty liver disease - who and how? Clinical and molecular hepatology (2023)
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing. Clinical and molecular hepatology (2023)
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase. Clinical and molecular hepatology (2023)
Richie Manikat, Mindie H Nguyen
NAFLD and Non-Liver Comorbidities. Clinical and molecular hepatology (2023)
Do-Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan
Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region. Clinical and molecular hepatology (2023)
Byeong Geun Song, Dong Hyun Sinn
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease. Clinical and molecular hepatology (2023)
Kee-Huat Chuah, Wah-Kheong Chan
Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future. Clinical and molecular hepatology (2023)
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study. Clinical and molecular hepatology (2023)
Young-Joo Jin
The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review. Clinical and molecular hepatology (2023)
Ju-Yeon Cho, Won Sohn
The growing burden of non-alcoholic fatty liver disease on mortality. Clinical and molecular hepatology (2023)
Chen-Hua Liu, Jia-Horng Kao
Acute hepatitis C virus infection: clinical update and remaining challenges. Clinical and molecular hepatology (2023)
Eileen Laurel Yoon, Dae Won Jun
Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology. Clinical and molecular hepatology (2023)
Chia-Ming Chu, Yun-Fan Liaw
Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase". Clinical and molecular hepatology (2023)
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis. Clinical and molecular hepatology (2023)
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
The role of different viral biomarkers on the management of chronic hepatitis B For special issue 'Challenging issues in the treatment of viral hepatitis'. Clinical and molecular hepatology (2023)
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Clinical practice guideline and real-life practice in hepatocellular carcinoma: Korea perspective. Clinical and molecular hepatology (2023)
Seung Up Kim
Preface. Clinical and molecular hepatology (2023)

volume 29, number 2, 2023

Lynna Alnimer, Mazen Noureddin
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future. Clinical and molecular hepatology 29 (2) (2023)

volume 29, number 3, 2023

Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim, null null
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association. Clinical and molecular hepatology 29 (3) (2023)

volume 29, number 4, 2023

Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection. Clinical and molecular hepatology 29 (4) (2023)
Sung Uk Lee, Tae Hyun Kim
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma. Clinical and molecular hepatology 29 (4) (2023)

volume 29, number Suppl, 2023

Sang Bong Ahn
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments. Clinical and molecular hepatology 29 (Suppl) (2023)
Seung Up Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Si Hyun Bae
Congratulatory remarks. Clinical and molecular hepatology 29 (Suppl) (2023)
Seung Up Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Si Hyun Bae
Congratulatory remarks. Clinical and molecular hepatology 29 (Suppl) (2023)
Richie Manikat, Mindie H Nguyen
Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and molecular hepatology 29 (Suppl) (2023)
Seung Up Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Richie Manikat, Mindie H Nguyen
Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and molecular hepatology 29 (Suppl) (2023)
Seung Up Kim
Special thanks. Clinical and molecular hepatology 29 (Suppl) (2023)
Yoon Jun Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Sang Bong Ahn
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments. Clinical and molecular hepatology 29 (Suppl) (2023)
Si Hyun Bae
Congratulatory remarks. Clinical and molecular hepatology 29 (Suppl) (2023)
Richie Manikat, Mindie H Nguyen
Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and molecular hepatology 29 (Suppl) (2023)
Sang Bong Ahn
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments. Clinical and molecular hepatology 29 (Suppl) (2023)
Sang Bong Ahn
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments. Clinical and molecular hepatology 29 (Suppl) (2023)
Yoon Jun Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Yoon Jun Kim
Preface. Clinical and molecular hepatology 29 (Suppl) (2023)
Richie Manikat, Mindie H Nguyen
Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and molecular hepatology 29 (Suppl) (2023)